Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Obstructive sleep apnea syndrome (OSAS) is a sleep-disordered breathing characterized by the occurrence of repeated upper airway obstructions leading to airflow reduction (hypopnea) or cessation (apnea). The apnea-hypopnea index (AHI) is the number of apneas and hypopneas per hour of sleep. OSA patients often report cognitive complaints.
About 25% of the elderly population is affected by this syndrome with a drastic increase of this rate among dementia patients. OSAS is considered to be an important risk factor for the development of hypertension, heart disease and stroke.
Numerous studies pointed out the close relationship between sleep apnea and cognitive impairment. To the investigators' knowledge, no trials have assessed the existence of a relationship between the IAH index and the cerebral arterial blood flow rate (macrocirculation). Developments in magnetic resonance imaging (MRI) provide new insights into the quantitative study of blood flow through phase contrast MRI also called "flow MRI". The main hypothesis tested in this study is the existence of a relationship between OSAS and total cerebral arterial vascular inflow measured by PC-MRI (in mL/min) in the elderly population.
Primary outcome: The apnea/hypopnea index (measured by nocturnal respiratory polygraphy) and total arterial flow rate (measured by PC-MRI)
Secondary outcomes:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dementia group | Experimental | Assessed by the insertion of an interaction parameter between cerebral blood flow and the group label(dementia or no-dementia). ROC method will be used to find a threshold value of IAH that separates the two groups. Interventions:
|
|
| control group | Other | Assessed by the insertion of an interaction parameter between cerebral blood flow and the group label(dementia or no-dementia). ROC method will be used to find a threshold value of IAH that separates the two groups. Interventions:
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vascular flow measurement by PC-MRI | Other | participants will undergo vascular flow measurement by PC-MRI at intra and extracranial levels |
|
| Measure | Description | Time Frame |
|---|---|---|
| Total arterial flowrate (measured by PC-MRI debit ml/Mn) | at day 1 after inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| sleep apnea measured by elderly polygraphy (Number of apneas / night) | at day 1 after inclusion up to 24 heures |
Not provided
Inclusion Criteria:
Elderly patients about or over 75 years
Any gender
Dementia Group:
3.1. MMSE (Mini Mental State Examination)> 15
3.2. Diagnosis of dementia established according to DSM-IV
3.3. Dementia of the Alzheimer type from NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association)
Control Group:
Preserved cognitive function corresponding to a normal MMSE score by the standards of Poitrenaud
Ability to understand and give consent freely (for demented subjects, a legal representative will be delegate)
Exclusion Criteria:
Elderly patients under 75 years
Anyone with a classic contraindication to MRI
2.1 Major behavioral disorders that do not allow the realization of MRI in optimal conditions
2.2 Claustrophobia
2.3 Presence of foreign non-compliant material
2.4 Presence of intraocular metal body
Having a history of chest surgery or neurosurgical
Chronic respiratory failure
Suffering from dementia other than that associated with Alzheimer's disease
Patients with a handicap
Patients under legal protection
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| ATTIER Jadwiga, MD | Contact | 0033323067216 | j.attier@ch-stquentin.fr | |
| BOULANOPUAR Abdelkrim, CRA | Contact | 0033323067861 | a.boulanouar@ch-stquentin.fr |
| Name | Affiliation | Role |
|---|---|---|
| ATTIER Jadwiga, MD | CH SAINT-QUENTIN | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CH Saint-Quentin | Recruiting | Saint-Quentin | 02100 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| D012891 | Sleep Apnea Syndromes |
| D003704 | Dementia |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D024801 | Tauopathies |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D019636 |
| Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D020919 | Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |